Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines

Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines

The SARS-CoV-2 pandemic has, as of July 2022, infected more than 550 million people and caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed to protect against severe disease, hospitalization and death. In the present study, we performed a direct comparative analys...

Full description

Bibliographic Details
Main Authors: Astrid K. Hvidt, Eva A. M. Baerends, Ole S. Søgaard, Nina B. Stærke, Dorthe Raben, Joanne Reekie, Henrik Nielsen, Isik S. Johansen, Lothar Wiese, Thomas L. Benfield, Kasper K. Iversen, Ahmed B. Mustafa, Maria R. Juhl, Kristine T. Petersen, Sisse R. Ostrowski, Susan O. Lindvig, Line D. Rasmussen, Marianne H. Schleimann, Sidsel D. Andersen, Anna K. Juhl, Lisa L. Dietz, Signe R. Andreasen, Jens Lundgren, Lars Østergaard, Martin Tolstrup, the ENFORCE Study Group
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
COVID-19
SARS-CoV-2
vaccines
antibodies
immunity
neutralization
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.994160/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.994160/full

Similar Items